Skip to main content

Table 1 Study population validation reference comparison of PROMs with a HRQoL component to those without

From: The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada

Validation of PROM

HRQL PROM n (%)

Non-HRQL measure n (%)

Total n (%)

Not validated

20 (33)

15 (33)

35

Validateda

36 (60)

26 (58)

62

No reference given

4 (7)

4 (9)

8

Total

60

45

105 (p = 0.910)

  1. aValidation not evaluated